News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
40 Under 40
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
40 Under 40
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
108,145 Results
Type
Article (4251)
Company Profile (18)
Press Release (103876)
Section
Business (31968)
Career Advice (108)
Deals (5249)
Drug Delivery (5)
Drug Development (5406)
Employer Resources (11)
FDA (3200)
Job Trends (2076)
News (46953)
Policy (3871)
Tag
Academia (363)
Allergies (9)
Alliances (11180)
ALS (6)
Alzheimer's disease (316)
Antibody-drug conjugate (ADC) (5)
Approvals (3211)
Artificial intelligence (91)
Autoimmune disease (1)
Automation (4)
Bankruptcy (46)
Best Places to Work (1718)
BIOSECURE Act (1)
Biosimilars (7)
Biotechnology (10)
Bladder cancer (11)
Brain cancer (6)
Breast cancer (63)
Cancer (439)
Cardiovascular disease (26)
Career advice (99)
Career pathing (1)
CAR-T (9)
Cell therapy (24)
Cervical cancer (7)
Clinical research (4192)
Collaboration (180)
Compensation (16)
COVID-19 (481)
C-suite (38)
Cystic fibrosis (9)
Data (258)
Decentralized trials (1)
Depression (6)
Diabetes (17)
Diagnostics (5823)
Digital health (7)
Diversity (1)
Diversity, equity & inclusion (3)
Drug discovery (14)
Drug pricing (3)
Drug shortages (1)
Duchenne muscular dystrophy (5)
Earnings (10500)
Employer branding (2)
Employer resources (11)
Events (13586)
Executive appointments (114)
FDA (3392)
Fibrodysplasia Ossificans Progressiva (1)
Funding (126)
Gene editing (1)
Generative AI (8)
Gene therapy (14)
GLP-1 (40)
Government (624)
Guidances (9)
Healthcare (2908)
IgA nephropathy (1)
Immunology and inflammation (6)
Indications (2)
Infectious disease (510)
Inflammatory bowel disease (13)
Influenza (12)
Intellectual property (7)
Interviews (12)
IPO (1798)
IRA (1)
Job creations (401)
Job search strategy (94)
Kidney cancer (5)
Labor market (1)
Layoffs (24)
Leadership (1)
Legal (533)
Liver cancer (11)
Lung cancer (48)
Lymphoma (33)
Machine learning (2)
Management (3)
Manufacturing (44)
MASH (7)
Medical device (2462)
Medtech (2462)
Mergers & acquisitions (3543)
Metabolic disorders (37)
Multiple sclerosis (20)
NASH (4)
Neurodegenerative disease (11)
Neuropsychiatric disorders (1)
Neuroscience (374)
NextGen: Class of 2025 (703)
Non-profit (547)
Now hiring (2)
Obesity (13)
Opinion (11)
Ovarian cancer (13)
Pain (4)
Pancreatic cancer (10)
Parkinson's disease (15)
Partnered (3)
Patents (22)
Patient recruitment (9)
Peanut (4)
People (8991)
Pharmaceutical (1)
Phase I (1263)
Phase II (1757)
Phase III (1613)
Pipeline (146)
Policy (2)
Postmarket research (212)
Preclinical (591)
Press Release (11)
Prostate cancer (38)
Psychedelics (1)
Radiopharmaceuticals (120)
Rare diseases (29)
Real estate (862)
Recruiting (5)
Regulatory (3019)
Reports (10)
Research institute (425)
Resumes & cover letters (15)
Rett syndrome (1)
Schizophrenia (1)
Series A (16)
Series B (12)
Service/supplier (2)
Sickle cell disease (1)
Spinal muscular atrophy (10)
Sponsored (5)
Startups (623)
Stomach cancer (2)
Supply chain (6)
The Weekly (1)
Vaccines (41)
Venture capitalists (6)
Weight loss (4)
Women's health (6)
Date
Today (6)
Last 7 days (108)
Last 30 days (356)
Last 365 days (4826)
2025 (1682)
2024 (5120)
2023 (6128)
2022 (10210)
2021 (9619)
2020 (8994)
2019 (6146)
2018 (4851)
2017 (5399)
2016 (5389)
2015 (6109)
2014 (4629)
2013 (4126)
2012 (4434)
2011 (4628)
2010 (4078)
Location
Africa (131)
Alabama (6)
Alaska (1)
Arizona (59)
Arkansas (2)
Asia (5336)
Australia (1251)
California (796)
Canada (263)
China (33)
Colorado (56)
Connecticut (63)
Delaware (7)
Europe (15221)
Florida (106)
Georgia (38)
Idaho (4)
Illinois (106)
India (4)
Indiana (34)
Iowa (4)
Japan (23)
Kansas (11)
Kentucky (4)
Louisiana (1)
Maine (20)
Maryland (102)
Massachusetts (426)
Michigan (65)
Minnesota (75)
Missouri (28)
Montana (4)
Nebraska (8)
Nevada (1)
New Hampshire (18)
New Jersey (147)
New Mexico (17)
New York (303)
North Carolina (185)
North Dakota (6)
Northern California (362)
Ohio (31)
Oklahoma (2)
Oregon (7)
Pennsylvania (83)
Rhode Island (5)
South America (154)
South Carolina (4)
Southern California (294)
Tennessee (31)
Texas (181)
United States (3195)
Utah (85)
Virginia (38)
Washington D.C. (6)
Washington State (78)
Wisconsin (33)
108,145 Results for "perspectum diagnostics".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
New Published Data Show Reproducibility and Utility of Perspectum’s MRI in Patients With Metabolic Liver Disease
September 27, 2024
·
3 min read
Press Releases
Perspectum Awarded New FDA Grant to Evaluate Biomarker for Rare Disease Drug Development
November 14, 2024
·
3 min read
Lone Star Bio
Perspectum Completes $19 Million Second Close of Series C Funding Led by Oppenheimer & Co. Inc. (“Oppenheimer”)
Perspectum has completed the second close of its $55 million Series C funding round.
March 15, 2023
·
3 min read
Lone Star Bio
Perspectum Completes $36 Million First Close of Series C Funding Led by Oppenheimer Holdings
Perspectum, a precision health company which develops medical imaging tools to improve the diagnoses of metabolic diseases and cancer, has completed the first close of its Series C funding round.
January 5, 2023
·
3 min read
Partnered
Ending the Diagnostic Odyssey for Patients
Ending the diagnostic journey for patients, particularly those with rare diseases, improves patients’ quality of life while reducing costs to healthcare systems.
December 11, 2024
·
4 min read
·
BioSpace Insights
Press Releases
Effective May 2, 2025, Interpace Diagnostics® Will No Longer Accept Specimens for PancraGEN®, a Molecular Diagnostic Test That Assesses Pancreatic Cyst Cancer Risk
April 25, 2025
·
6 min read
Business
New Partnership Between Marubeni/Clairvo and Perspectum to Bring LiverMultiScan to Japan
Perspectum announced that it has signed a strategic business partnership with Marubeni Corporation to support entry of Perspectum’s AI diagnostic technology, called LiverMultiScan, into the Japanese market.
May 26, 2021
·
2 min read
Business
Perspectum and HepQuant Announce Partnership to Bring a More Complete Picture of Liver Health
Perspectum and HepQuant are proud to announce a strategic business partnership to provide seamless delivery of HepQuant’s liver function assessment technology via Perspectum’s Contract Research Organization (CRO) services.
November 1, 2021
·
3 min read
Press Releases
Cleveland Diagnostics Announces Landmark Longitudinal Study Published in Urology
April 23, 2025
·
3 min read
Press Releases
Newly-formed Archerfish Precision Diagnostics Pte Ltd: Ushers a New Era in Advanced Diagnostics
March 6, 2025
·
5 min read
1 of 10,815
Next
